GAMCO Investors’s CONMED CNMD Stock Holding History

GAMCO Investors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.02M	Hold	57,200	–	–	0.02%	515
2025 Q4	$2.32M	Hold	57,200	–	–	0.02%	502
2025 Q3	$2.69M	Hold	57,200	–	–	0.03%	474
2025 Q2	$2.98M	Hold	57,200	–	–	0.03%	464
2025 Q1	$3.45M	Hold	57,200	–	–	0.04%	403
2024 Q4	$3.91M	Hold	57,200	–	–	0.04%	387
2024 Q3	$4.11M	Hold	57,200	–	–	0.04%	373
2024 Q2	$3.97M	Sell	57,200 -200	-0.3%	-$14.6K	0.04%	377
2024 Q1	$4.6M	Hold	57,400	–	–	0.05%	352
2023 Q4	$6.29M	Sell	57,400 -150	-0.3%	-$15.5K	0.07%	301
2023 Q3	$5.8M	Hold	57,550	–	–	0.07%	297
2023 Q2	$7.82M	Sell	57,550 -500	-0.9%	-$61K	0.08%	262
2023 Q1	$6.03M	Hold	58,050	–	–	0.06%	295
2022 Q4	$5.15M	Hold	58,050	–	–	0.06%	308
2022 Q3	$4.65M	Hold	58,050	–	–	0.05%	317
2022 Q2	$5.56M	Sell	58,050 -400	-0.7%	-$48K	0.06%	297
2022 Q1	$8.68M	Sell	58,450 -900	-2%	-$126K	0.08%	260
2021 Q4	$8.41M	Sell	59,350 -150	-0.3%	-$21.2K	0.07%	275
2021 Q3	$7.78M	Hold	59,500	–	–	0.07%	288
2021 Q2	$8.18M	Sell	59,500 -2,200	-4%	-$301K	0.07%	288
2021 Q1	$8.06M	Sell	61,700 -500	-0.8%	-$60.2K	0.07%	274
2020 Q4	$6.97M	Sell	62,200 -700	-1%	-$66.3K	0.07%	292
2020 Q3	$4.95M	Sell	62,900 -300	-0.5%	-$24.5K	0.05%	327
2020 Q2	$4.55M	Sell	63,200 -800	-1%	-$55.7K	0.05%	322
2020 Q1	$3.67M	Sell	64,000 -900	-1%	-$83K	0.04%	340
2019 Q4	$7.26M	Sell	64,900 -2,400	-4%	-$256K	0.06%	301
2019 Q3	$6.47M	Sell	67,300 -3,000	-4%	-$282K	0.05%	308
2019 Q2	$6.02M	Sell	70,300 -1,400	-2%	-$115K	0.05%	328
2019 Q1	$5.96M	Sell	71,700 -1,000	-1%	-$72.7K	0.05%	327
2018 Q4	$4.67M	Hold	72,700	–	–	0.04%	339
2018 Q3	$5.76M	Sell	72,700 -4,400	-6%	-$340K	0.04%	339
2018 Q2	$5.64M	Sell	77,100 -2,300	-3%	-$156K	0.04%	341
2018 Q1	$5.03M	Sell	79,400 -9,000	-10%	-$537K	0.03%	353
2017 Q4	$4.51M	Sell	88,400 -200	-0.2%	-$10.4K	0.03%	375
2017 Q3	$4.65M	Hold	88,600	–	–	0.03%	375
2017 Q2	$4.51M	Hold	88,600	–	–	0.03%	385
2017 Q1	$3.94M	Hold	88,600	–	–	0.02%	410
2016 Q4	$3.91M	Sell	88,600 -200	-0.2%	-$8.5K	0.02%	410
2016 Q3	$3.56M	Hold	88,800	–	–	0.02%	424
2016 Q2	$4.24M	Hold	88,800	–	–	0.03%	393
2016 Q1	$3.72M	Sell	88,800 -700	-0.8%	-$27.5K	0.02%	411
2015 Q4	$3.94M	Sell	89,500 -300	-0.3%	-$13K	0.03%	397
2015 Q3	$4.29M	Sell	89,800 -300	-0.3%	-$16.5K	0.03%	392
2015 Q2	$5.25M	Sell	90,100 -1,600	-2%	-$86.3K	0.03%	389
2015 Q1	$4.63M	Hold	91,700	–	–	0.02%	410
2014 Q4	$4.12M	Sell	91,700 -400	-0.4%	-$16.8K	0.02%	424
2014 Q3	$3.39M	Sell	92,100 -200	-0.2%	-$7.93K	0.02%	457
2014 Q2	$4.08M	Sell	92,300 -700	-0.8%	-$31.7K	0.02%	424
2014 Q1	$4.04M	Sell	93,000 -200	-0.2%	-$8.91K	0.02%	422
2013 Q4	$3.96M	Sell	93,200 -700	-0.7%	-$26.6K	0.02%	418
2013 Q3	$3.19M	Hold	93,900	–	–	0.02%	447
2013 Q2	$2.93M	Buy	+93,900	New	+$3.05M	0.02%	433

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

GAMCO Investors's CNMD Position: Q1 2026 in Review

GAMCO Investors held its CONMED (CNMD) position steady in Q1 2026 at 57,200 shares worth $2.02M. The position accounts for 0.02% of the portfolio, ranked #515.

GAMCO Investors first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.68M in Q1 2022. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

GAMCO Investors held 57,200 shares of CONMED worth $2.02M as of Q1 2026.
GAMCO Investors left its CONMED share count unchanged in Q1 2026.
CONMED made up 0.02% of GAMCO Investors's portfolio in Q1 2026, its #515 holding.
GAMCO Investors first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
GAMCO Investors's CONMED position peaked at $8.68M in Q1 2022.
236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.